EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/15/2023
Back to search
Official data from USPTO
A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH
ST13
US500000090809062Class
42
Filing
90809062
Registration
6791631
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
09/15/2023
Trademark type
Word
Nice classes
42
Filing date
07/02/2021
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
09/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
08/08/1996
First use in commerce
08/08/1996
Drawing code
4
Owner type
16
Owner location
Hamilton, NJ
Examiner
SHOOR, AMIT
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ELIM Holdings, LLC
Representatives
Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of toxicologypharmacokineticspharmacologydermatologyocular studiesefficacygood laboratory practiceshistopathologyimmunohistochemistry and T cell receptors; Research and development in the field of toxicologypharmacokineticspharmacologydermatologyocular studiesefficacygood laboratory practiceshistopathologyimmunohistochemistry and T cell receptors.; Scientific research for medical purposes in the field of toxicologypharmacokineticspharmacologydermatologyocular studiesefficacygood laboratory practiceshistopathologyimmunohistochemistry and T cell receptors
Publications
History of USPTO decisions and trademark events.
23 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2023
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/12/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/06/2022
ALIE
ASSIGNED TO LIE
06/02/2022
ALIE
ASSIGNED TO LIE
05/27/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/20/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/18/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/18/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/18/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2021
GNRT
NON-FINAL ACTION E-MAILED
11/19/2021
CNRT
NON-FINAL ACTION WRITTEN
11/19/2021
DOCK
ASSIGNED TO EXAMINER
11/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/14/2021
NWAP
NEW APPLICATION ENTERED
07/06/2021
Continuous trademark protection
Get notified about every new filing that threatens A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.